•
Sep 30, 2012

Pfizer Q3 2012 Earnings Report

Total Revenue
$14B
Previous year: $17.2B
-18.7%
EPS
$0.53
Previous year: $0.48
+10.4%
Gross Profit
$11.3B
Previous year: $13.5B
-16.3%
Cash and Equivalents
$4.51B
Previous year: $3.71B
+21.6%
Free Cash Flow
$4.72B
Previous year: $3.99B
+18.4%
Total Assets
$183B
Previous year: $196B
-6.9%

Pfizer

Pfizer